Patents Assigned to Fleming & Company
  • Patent number: 5939394
    Abstract: The present invention relates to compositions and methods for the prevention and/or treatment of allergic, autoimmune, septic shock or infectious diseases using magnesium gluconate alone or in combination with one or more antioxidants or an antiinflammatory agent. The invention also relates to the inhibition of production of inappropriate levels of lipid mediators and cytokines.
    Type: Grant
    Filed: April 23, 1997
    Date of Patent: August 17, 1999
    Assignee: Fleming & Company
    Inventors: Thomas E. Fleming, Herbert C. Mansmann, Jr.